11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2021
-
Mark
Role of CRISPR/Cas9 and other gene editing/engineering technology in intestine diseases
2021) p.75-86(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
CRISPR/CAS9 BASED DNA-COMBING ASSAY FOR DETECTING ANTIMICROBIAL RESISTANCE GENES ON PLASMIDS
2021) 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2021 p.801-802(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
CRISPR/Cas9 Genome Engineering in Human Pluripotent Stem Cells for Modeling of Neurological Disorders
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
Optical DNA Mapping Combined with Cas9-Targeted Resistance Gene Identification for Rapid Tracking of Resistance Plasmids in a Neonatal Intensive Care Unit Outbreak
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling
(
- Contribution to journal › Article
-
Mark
Vi måste ta ställning till den nya gentekniken
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
- 2018
-
Mark
A new genetic tool to improve immune-compromised mouse models : Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines
(
- Contribution to journal › Article
-
Mark
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1
(
- Contribution to journal › Article
- 2016
-
Mark
Detailed characterization of plasmids carrying resistance genes using optical DNA mapping
2016) 20th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2016 p.1561-1562(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- « previous
- 1
- 2
- next »